Advertisement

Topics

STAT Plus: Pharmalittle: Stronger warnings urged for Amgen’s osteoporosis drug; prices in drug ads can be jarring

08:42 EDT 17 Apr 2019 | STAT

Public Citizen is urging the FDA to require stronger warnings about an increased risk of spinal fractures when patients stop taking the Prolia.

Original Article: STAT Plus: Pharmalittle: Stronger warnings urged for Amgen’s osteoporosis drug; prices in drug ads can be jarring

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: Stronger warnings urged for Amgen’s osteoporosis drug; prices in drug ads can be jarring"

Advertisement
Quick Search
Advertisement
Advertisement